REFUGE BIOTECHNOLOGIES INC has a total of 15 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are ANHUI SINOBIOWAY CELL THERAPY CO LTD, WANG YUEJU and GX BIOSYSTEMS AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | United States | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Therapeutic chemical compounds | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Wang Jianbin | 13 |
#2 | Liu Pei-Qi | 11 |
#3 | Wang Bing | 9 |
#4 | Yang Zhifen | 1 |
#5 | Li Lingyu | 1 |
#6 | Liu Pei Qi | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020227307A1 | Systems and methods for nuclear localization of gene modulating polypeptides | |
WO2020172627A2 | Chimeric polypeptides and methods of using the same | |
WO2019183572A1 | Gene regulation via conditional nuclear localization of gene modulating polypeptides | |
CN111093679A | Methods and systems for conditional regulation of gene expression |